| 0.2 0 (0%) | 01-16 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 1-year : | ||
| Resists | First : | Second : | ||
| Pivot price | ||||
| Supports | First : | Second : | ||
| MAs | MA(5) : | MA(20) : | ||
| MA(100) : | MA(250) : | |||
| MACD | MACD : | Signal : | ||
| %K %D | K(14,3) : | D(3) : | ||
| RSI | RSI(14): | |||
| 52-week | High : | Low : | ||
| If tomorrow: | Open lower | Open higher |
| High: | - | - |
| Low: | - | - |
| Close: | - | - |
Neptune Wellness Solutions Inc. functions as an all-encompassing health and wellness company, with operations spanning Canada, the United States, and various international regions. The firm actively develops and markets its own collection of consumer lifestyle brands and packaged goods, including names such as Biodroga, Forest Remedies, Ocean Remedies, Neptune Wellness, Mood Ring, PanHash, Sprout, Nosh, MaxSimil, and NurturMe. Beyond its proprietary brands, Neptune offers complete product development and supply chain services to corporate clients across diverse health and wellness sectors, which encompass nutraceuticals, beauty and personal care items, and organic food and beverage products. The company is also proficient in the entire process of producing health and wellness goods, from initial extraction and purification to final formulation and manufacturing. A significant innovation from Neptune is MaxSimil, an advanced delivery system for omega-3 fatty acids. This technology employs enzymes that mimic the natural human digestive system to pre-digest omega-3s, thereby improving their absorption. Furthermore, the company has forged a partnership with International Flavors & Fragrances Inc. to jointly create hemp-derived CBD products specifically for the mass retail and wider health and wellness markets. Established in 1998, Neptune Wellness Solutions Inc. is headquartered in Laval, Canada.
Tue, 30 Apr 2024
Neptune Wellness Solutions insider sells shares worth over $21k - Investing.com
Fri, 05 Apr 2024
Neptune Wellness Solutions Inc. (NEPT) Share Price Today | Neptune Wellness Solutions (NEPT) Live NSE/BSE - Value Research
Fri, 08 Mar 2024
Neptune Appoints Interim President and CEO and Interim COO - Stock Titan
Wed, 06 Mar 2024
Neptune Wellness to be delisted from Nasdaq - Investing.com
Wed, 29 Nov 2023
Neptune Wellness Nutraceutical Brand, Biodroga, Announces Accounts Receivable Factoring Facility of Up to $8 Million - PR Newswire Canada
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Drug Manufacturers - Specialty & Generic
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | (%) |
| Held by Institutions | (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | |
| EPS Est Next Qtrly | |
| EPS Est This Year | |
| EPS Est Next Year | |
| Book Value (p.s.) | |
| Profit Margin | % |
| Operating Margin | % |
| Return on Assets (ttm) | % |
| Return on Equity (ttm) | % |
| Qtrly Rev. Growth | % |
| Gross Profit (p.s.) | |
| Sales Per Share | |
| EBITDA (p.s.) | |
| Qtrly Earnings Growth | % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | |
| PEG Ratio | |
| Price to Book value | |
| Price to Sales | |
| Price to Cash Flow |
| Dividend | |
| Forward Dividend | |
| Dividend Yield | 0% |
| Dividend Pay Date | |
| Ex-Dividend Date |
|
|
|
|
|
|
|
|
|